Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 1, 1997

View Archived Issues

Encouraging phase I results for porcine neural cell product

Lysostaphin found superior to vancomycin in treating MRSA

SNX-111 clinical data presented at international pain meeting

U.S. patent issued for Cell Genesys CNS gene therapy

IL-2 + IFN-alpha in phase II for renal cell carcinoma

Protective effects of Bayer's LTD4 antagonist demonstrated in asthmatic subjects

Antibacterial mutilin derivatives

Cytokine inhibitors presented by SKB

Peptidoleukotrienes and TxA2 both implicated in cough variant asthma

New bradykinin antagonists from Sanofi

Antileukotriene effects described for ebastine

HIV protease inhibitors under development at Vertex

Gene therapy for AIDS in development at Theratechnologies

Pharmacia & Upjohn continues SAR studies on oxazolidinones

New treatment for ISH evaluated in humans

Single- and multiple-dose clinical studies reported for SL-91.0102

New agents for NIDDM presented by Pharmacia & Upjohn

A-5021: a potent and selective antiherpesvirus agent from Ajinomoto

Launch announced for new ulcerative colitis Rx

Third pivotal trial of VX-478 commences

RPR seeks U.K. approval for Synercid

Matrix announces restructuring to focus on oncology products

Interstim approved for marketing in U.S.

Phase I/II data on MEDI-493 presented at ICAAC

Xoma's XMP peptides display antifungal activity

Preclinical pharmacokinetic/efficacy data on MiKasome presented at ICAAC

ABT-606: a new orally active diester prodrug of H2G

Collaborators demonstrate protection against HSV with Cel-Sci vaccine

Camptosar available in Canada

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...